SILO — Silo Pharma, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1514183 ·
Last close
$1.71
Market Cap
$4.00M
52W High
$10.43
52W Low
$1.10
ADV30
41,745
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | 0 | -928,949 | -832,829 | 5,952,023 | 3,277,095 | 1,065,733 |
| Mar 2026 | 18,026 | -2,662 | -1,594,660 | -1,647,117 | 7,018,132 | 3,902,514 | 1,336,296 |
| Dec 2025 | 18,026 | -2,663 | -786,524 | -881,530 | 7,605,100 | 4,748,700 | 1,299,659 |
| Sep 2025 | 18,025 | -2,662 | -1,151,466 | -1,110,438 | 6,384,681 | 3,917,627 | 1,375,841 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-3,340,255
Investing CF
$-455,586
Financing CF
$4,860,219
CapEx
$-49,990
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-7.24
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-21,972,335
Inventory
—
Receivables
—
ST Investments
$2,155,561
EBIT TTM
$-4,432,088
Pretax Income TTM
$-4,471,914
Interest Exp TTM
$39,826
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$54,077
EBITDA
$-4,449,849
Free Cash Flow
$-1,642,196
Enterprise Value
$-2,304,862
Total Cash
$5,227,242
Total Debt
$0
Shares Out
2,339,255
Trailing EPS
$-4.26
Book Value
$7.10
ROE
-91.2%
ROA
-44.2%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 72,102 | -4,280,662 | -4,227,698 | 7,605,100 | 1,299,659 | 6,305,441 | -4,661,339 |
| Dec 2024 | 72,102 | -4,705,694 | -4,392,880 | 7,411,840 | 2,377,575 | 5,034,265 | -3,833,914 |
| Dec 2023 | 72,102 | -3,855,592 | -3,700,683 | 7,746,141 | 1,569,270 | 6,176,871 | -3,224,498 |
| Dec 2022 | 72,102 | -3,647,656 | -3,908,551 | 11,642,877 | 1,302,100 | 10,340,777 | -3,497,622 |
TTM Snapshot
Revenues TTM
$54,077
NetIncome TTM
$-4,471,914
OpCashFlow TTM
—
Assets (Latest)
$5,952,023
Forward EPS
$-0.70
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS, INC. | $4.02M | $0.31 | — |
| XTLB | XTL BIOPHARMACEUTICALS LTD | $3.98M | $1.62 | — |
| IMNN | Imunon, Inc. | $3.97M | $0.61 | — |
| KPRX | KIORA PHARMACEUTICALS INC | $4.11M | $0.93 | — |
| TCRT | Alaunos Therapeutics, Inc. | $4.22M | $1.66 | — |
News headlines (Yahoo Finance, 1h cache)
Is Silo Pharma, Inc. (SILO) Stock an AI Opportunity After NVIDIA Partnership Boosts QwikAgents Platform?
2026-07-15 09:22 · Yahoo
Silo Pharma Shares Slide After Announcing Up to $11.7 Million Private Placement (SILO)
2026-07-10 14:03 · Yahoo
CCC Intelligent Solutions, Circle rise premarket; Silo Pharma, Fermi America fall
2026-07-10 12:57 · Yahoo
Silo Pharma’s QwikAgents Joins AMD AI Developer Program to Advance AI Agent Platform
2026-07-14 14:42 · Yahoo
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
2026-05-04 15:11 · Yahoo
Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform
2026-07-14 12:55 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.